ENAH
Protein enabled homolog
Also known as: ENAH_HUMAN, FLJ10773, MENA, NDPP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N8S7
- Gene
- ENAH
- Ensembl
- ENSG00000154380
- Chromosome
- 1
- Canonical length
- 591 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Focal adhesion sites,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the enabled/ vasodilator-stimulated phosphoprotein. Members of this gene family are involved in actin-based motility. This protein is involved in regulating the assembly of actin filaments and modulates cell adhesion and motility. Alternate splice variants of this gene have been correlated with tumor invasiveness in certain tissues and these variants may serve as prognostic markers. A pseudogene of this gene is found on chromosome 3. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
591 residues, UniProt reviewed canonical sequence.
>Q8N8S7|ENAH
1 MSEQSICQAR AAVMVYDDAN KKWVPAGGST GFSRVHIYHH TGNNTFRVVG RKIQDHQVVI
61 NCAIPKGLKY NQATQTFHQW RDARQVYGLN FGSKEDANVF ASAMMHALEV LNSQETGPTL
121 PRQNSQLPAQ VQNGPSQEEL EIQRRQLQEQ QRQKELERER LERERMERER LERERLERER
181 LERERLEQEQ LERERQERER QERLERQERL ERQERLERQE RLDRERQERQ ERERLERLER
241 ERQERERQEQ LEREQLEWER ERRISSAAAP ASVETPLNSV LGDSSASEPG LQAASQPAET
301 PSQQGIVLGP LAPPPPPPLP PGPAQASVAL PPPPGPPPPP PLPSTGPPPP PPPPPLPNQV
361 PPPPPPPPAP PLPASGFFLA SMSEDNRPLT GLAAAIAGAK LRKVSRMEDT SFPSGGNAIG
421 VNSASSKTDT GRGNGPLPLG GSGLMEEMSA LLARRRRIAE KGSTIETEQK EDKGEDSEPV
481 TSKASSTSTP EPTRKPWERT NTMNGSKSPV ISRRDSPRKN QIVFDNRSYD SLHRPKSTPL
541 SQPSANGVQT EGLDYDRLKQ DILDEMRKEL TKLKEELIDA IRQELSKSNT ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENAH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 38 nTPM
- smooth muscle: 38 nTPM
- colon: 24 nTPM
- urinary bladder: 19 nTPM
- stomach: 19 nTPM
- testis: 18 nTPM
Single-cell type
- smooth muscle cells: 693 nCPM
- sertoli cells: 615 nCPM
- endometrial ciliated cells: 482 nCPM
- pituitary stem cells: 469 nCPM
- myonuclei: 452 nCPM
- mucous neck cells: 452 nCPM
Immune cell
- naive B-cell: 0.2 nTPM
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 108 nTPM
- hypothalamus: 99 nTPM
- midbrain: 94 nTPM
- medulla oblongata: 86 nTPM
- amygdala: 86 nTPM
- pons: 85 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ENAH.
Disease | ImmuneIEDB
Conditions an epitope on ENAH was assayed in.
- collecting duct carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.74
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin polymerization or depolymerization
- actin polymerization-dependent cell motility
- axon guidance
- postsynaptic cytoskeleton organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ENAH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENAH as an antibody target. Whether an autoantibody or antibody against ENAH could matter depends on whether native ENAH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENAH is annotated at the cell surface, where native ENAH is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ENAH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...